Furthermore, a quantitative post-mortem pathological study has demonstrated a higher hyper-phosphorylated tau burden in neuropathologically mixed AD+DLB cases that had a clinical presentation of AD compared with those with a DLB phenotype [20]. This evidence concerns the gene MAPT and Lewy body dementia.